Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeated versus single Vistabel plus Juvéderm Ultra 2 for glabellar frown lines
2010-020057-13Phase 4Completed
- Sponsor
- Dermatologikum Hamburg
- Start
- Apr 2010
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of botulinum toxin type A and Juvéderm Ultra 2 in glabellar furrowing (3 arms), sponsored by Dermatologikum Hamburg. Primary endpoints: Response rate at visit 4 at rest and Response rate at visit 7 at rest. Started Apr 2010; status: completed.
02
Drugs
botulinum toxin type AJuvéderm Ultra 2
03
Conditions
glabellar furrowing
Beyond the preview
Go deeper on 2010-020057-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020057-13.